Thapa S, Li H, J OH, Bhatti S, Chen FC, Nasr KA, Johnson T, Zhou S (2019) <br />Biochemical Characteristics of Microbial Enzymes and Their Significance from Industrial Perspectives<br /><i>Mol Biotechnol</i> <b>61</b>: 579<br /><br />Millwood IY, Bennett DA, Walters RG, Clarke R, Waterworth D, Johnson T, Chen Y, Yang L, Guo Y, Bian Z, Hacker A, Yeo A, Parish S, Hill MR, Chissoe S, Peto R, Cardon L, Collins R, Li L, Chen Z (2016) <br />A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults<br /><i>Int J Epidemiol</i> <b>45</b>: 1588<br /><br />Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P (2012) <br />Donepezil and memantine for moderate-to-severe Alzheimer's disease<br /><i>N Engl J Med</i> <b>366</b>: 893<br /><br />Patterson SK, Borewicz K, Johnson T, Xu W, Isaacson RE (2012) <br />Characterization and differential gene expression between two phenotypic phase variants in Salmonella enterica serovar Typhimurium<br /><i>PLoS ONE</i> <b>7</b>: e43592<br /><br />Ballard C, Brown R, Fossey J, Douglas S, Bradley P, Hancock J, James IA, Juszczak E, Bentham P, Burns A, Lindesay J, Jacoby R, O'Brien J, Bullock R, Johnson T, Holmes C, Howard R (2009) <br />Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)<br /><i>American Journal of Geriatry & Psychiatry</i> <b>17</b>: 726<br /><br />Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, Brown R, Burns A, Dening T, Findlay D, Gray R, Griffin M, Holmes C, Hughes A, Jacoby R, Johnson T, Knapp M, Lindesay J, McKeith I, McShane R, Macharouthu A, O'Brien J, Onions C, Passmore P, Raftery J, Ritchie C, Howard R (2009) <br />DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT<br /><i>Trials</i> <b>10</b>: 57<br /><br />Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M (2007) <br />Donepezil for the treatment of agitation in Alzheimer's disease<br /><i>N Engl J Med</i> <b>357</b>: 1382<br /><br />